[Prevention and countermeasures in kidney diseases complicated by hypertension].
Fujiwara
Y
Y
Takama
T
T
Orita
Y
Y
Kamada
T
T
D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000517:prevention & control*; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D009400:Nephrosclerosis / Q000209:etiology / Q000517:prevention & control*; D010982:Platelet-Derived Growth Factor / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D010982:Platelet-Derived Growth Factor; D000804:Angiotensin II